Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Metabolomic/lipidomic-based analysis of plasma to diagnose hepatocellular ballooning in patients with non-alcoholic fatty liver disease: A multicenter study.
Ogawa Y, Kobayashi T, Honda Y, Kessoku T, Tomeno W, Imajo K, Nakahara T, Oeda S, Nagaoki Y, Amano Y, Ando T, Hirayama M, Isono O, Kamiguchi H, Nagabukuro H, Ogawa S, Satomi Y, Saigusa Y, Takahashi H, Hyogo H, Yoneda M, Saito S, Yamanaka T, Aishima S, Eguchi Y, Kage M, Chayama K, Nakajima A. Ogawa Y, et al. Among authors: saigusa y. Hepatol Res. 2020 Aug;50(8):955-965. doi: 10.1111/hepr.13528. Epub 2020 Jul 15. Hepatol Res. 2020. PMID: 32455496
Differences in autonomic nervous system activity between long-acting injectable aripiprazole and oral aripiprazole in schizophrenia.
Hattori S, Suda A, Kishida I, Miyauchi M, Shiraishi Y, Noguchi N, Furuno T, Asami T, Fujibayashi M, Tsujita N, Ishii C, Ishii N, Saeki T, Fukushima T, Moritani T, Saigusa Y, Hishimoto A. Hattori S, et al. Among authors: saigusa y. BMC Psychiatry. 2023 Mar 3;23(1):135. doi: 10.1186/s12888-023-04617-y. BMC Psychiatry. 2023. PMID: 36869320 Free PMC article.
Protocol for a confirmatory trial of the effectiveness and safety of palliative arterial embolization for painful bone metastases.
Zenda S, Arai Y, Sugawara S, Inaba Y, Hashimoto K, Yamamoto K, Saigusa Y, Kawaguchi T, Shimada S, Yokoyama M, Miyaji T, Okano T, Nakamura N, Kobayashi E, Takagi T, Matsumoto Y, Uchitomi Y, Sone M; J-SUPPORT 1903, PALEM Trial. Zenda S, et al. Among authors: saigusa y. BMC Cancer. 2023 Jan 31;23(1):109. doi: 10.1186/s12885-023-10538-6. BMC Cancer. 2023. PMID: 36721103 Free PMC article.
Comparison of standardized prophylactic high-dose and intrathecal methotrexate for DLBCL with a high risk of CNS relapse.
Akimoto M, Miyazaki T, Takahashi H, Saigusa Y, Takeda T, Hibino Y, Tokunaga M, Ohashi T, Matsumura A, Teshigawara H, Suzuki T, Teranaka H, Nakajima Y, Matsumoto K, Hashimoto C, Fujimaki K, Fujita H, Sakai R, Fujisawa S, Nakajima H. Akimoto M, et al. Among authors: saigusa y. Int J Hematol. 2024 Feb;119(2):164-172. doi: 10.1007/s12185-023-03700-0. Epub 2024 Jan 17. Int J Hematol. 2024. PMID: 38233702
Exploratory randomized phase II trial for optimizing treatment dosage and duration of adjuvant S-1 plus oxaliplatin in patients with stage III colon cancer: YCOG1402 (SOAP trial).
Suwa Y, Watanabe J, Suwa H, Ozawa M, Momiyama M, Ishibe A, Nagamine K, Yamagishi S, Ota M, Fukushima T, Sekido H, Saigusa Y, Endo I. Suwa Y, et al. Among authors: saigusa y. Ann Gastroenterol Surg. 2023 Apr 30;7(6):922-931. doi: 10.1002/ags3.12687. eCollection 2023 Nov. Ann Gastroenterol Surg. 2023. PMID: 37927922 Free PMC article.
Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxin.
Ogawa Y, Imajo K, Honda Y, Kessoku T, Tomeno W, Kato S, Fujita K, Yoneda M, Saito S, Saigusa Y, Hyogo H, Sumida Y, Itoh Y, Eguchi K, Yamanaka T, Wada K, Nakajima A. Ogawa Y, et al. Among authors: saigusa y. Sci Rep. 2018 Jul 27;8(1):11365. doi: 10.1038/s41598-018-29735-6. Sci Rep. 2018. PMID: 30054551 Free PMC article.
Rationale and design of a randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated phase 2a study to investigate the efficacy and safety of elobixibat in combination with cholestyramine for non-alcoholic fatty liver disease.
Kessoku T, Kobayashi T, Ozaki A, Iwaki M, Honda Y, Ogawa Y, Imajo K, Saigusa Y, Yamamoto K, Yamanaka T, Usuda H, Wada K, Yoneda M, Saito S, Nakajima A. Kessoku T, et al. Among authors: saigusa y. BMJ Open. 2020 Sep 9;10(9):e037961. doi: 10.1136/bmjopen-2020-037961. BMJ Open. 2020. PMID: 32907904 Free PMC article.
Direct Comparison of US and MR Elastography for Staging Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Imajo K, Honda Y, Kobayashi T, Nagai K, Ozaki A, Iwaki M, Kessoku T, Ogawa Y, Takahashi H, Saigusa Y, Yoneda M, Kirikoshi H, Utsunomiya D, Aishima S, Saito S, Nakajima A. Imajo K, et al. Among authors: saigusa y. Clin Gastroenterol Hepatol. 2022 Apr;20(4):908-917.e11. doi: 10.1016/j.cgh.2020.12.016. Epub 2020 Dec 17. Clin Gastroenterol Hepatol. 2022. PMID: 33340780 Free article.
MRI-Based Quantitative R2* Mapping at 3 Tesla Reflects Hepatic Iron Overload and Pathogenesis in Nonalcoholic Fatty Liver Disease Patients.
Imajo K, Kessoku T, Honda Y, Hasegawa S, Tomeno W, Ogawa Y, Motosugi U, Saigusa Y, Yoneda M, Kirikoshi H, Yamanaka S, Utsunomiya D, Saito S, Nakajima A. Imajo K, et al. Among authors: saigusa y. J Magn Reson Imaging. 2022 Jan;55(1):111-125. doi: 10.1002/jmri.27810. Epub 2021 Jun 28. J Magn Reson Imaging. 2022. PMID: 34184822
131 results